Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Department
Adjust height of sidebar
KMap
Department
Dept of Emergency Medicine
27 active people
114 grants
Recent Grants
A Randomized Controlled Trial to Evaluate the Efficacy of Fomepizole in the Treatment of Acetaminophen Overdose at Increased Risk of Liver Injury
2024
·
$274.2K
pharmacology,
toxicology,
clinical trials,
hepatology,
emergency medicine
Consumer Product Commission Neiss Surveillance Report
2024
·
$90.8K
consumer products,
surveillance,
product safety,
commission reports,
risk management
A Phase 2a, Double-Blind, Randomized Adaptive Design, Placebo-Controlled, Parallel Group Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics and Biomarkers with Oral Colon Delivery
2024
·
$2.6K
clinical trial,
pharmacokinetics,
drug delivery,
safety assessment,
biomarkers
Randomized, Double-blinded, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Efficacy of Intravenous Varespladib Followed by Oral Varespladib in Addition to Standard of Care in Subje
2023
·
$1.5M
pharmaceuticals,
clinical trials,
drug efficacy,
safety assessment,
standard of care
A Phase III, Multicentre, Randomised, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tozorakimab (MEDI3506) in Patients Hospitalised for Viral Lung Infec
2023
·
$1.3M
clinical trials,
immunotherapy,
infectious diseases,
respiratory medicine,
drug safety
Automated Sonographic Detection of Pulmonary Embolism Using Machine Learning Algorithm
2023
·
$606.2K
medical imaging,
pulmonary embolism,
machine learning,
automated detection,
diagnostic technology
CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial
2023
·
$500K
calcium regulation,
vasopressin,
resuscitation,
injury,
clinical trial
PUERTA (Pioneering The Utility Of eNAMPT-Reducing Therapies In Acute Respiratory Distress Syndrome [ARDS]/ Ventilator-induced Lung Injury [VILI]): An Adaptive Phase 2a, Multi-center, Randomized, Doubl
2023
·
$498.4K
clinical trial,
respiratory distress,
drug efficacy,
safety assessment
1/2 PREcision VENTilation to attenuate Ventilation-Induced Lung Injury (PREVENT VlLI)
2023
·
$380K
ventilation,
lung injury,
precision medicine,
critical care,
respiratory therapy
A Multicenter, Randomized, Double-Blind, Parallel-Group Study to Assess the Efficacy and Safety of Oral Etrasimod as Induction and Maintenance Therapy for Moderately to Severely Active Crohn's Disease
2023
·
$306.6K
gastroenterology,
clinical trials,
therapeutics,
immunology
Reparixin 1200 Mg Three Times a Day as Add-on Therapy to Standard of Care to Limit Disease Progression in Hospitalised Adult Patients With Covid-19 Other Community-acquired Pneumonia. A Multinational,
2023
·
$302.9K
covid-19,
pneumonia,
therapy,
disease progression,
hospitalized patients
A Phase 2, Randomized, Double-blinded, Placebo-controlled, Parallel Group Study Evaluating the Efficacy and Safety of Amiselimod (Mt-1303) in Subjects With Mild to Moderate Ulcerative Colitis (UC)
2023
·
$240.8K
pharmacology,
gastroenterology,
clinical trials,
immunology,
drug safety
Siren CORE-EM Hub Alliance
2023
·
$116.6K
emergency response,
data integration,
network collaboration,
technology alliance,
community safety
Pediatric Dose Optimization for Seizures in EMS (PediDOSE)
2023
·
$62.2K
pediatrics,
seizures,
ems,
dosing,
optimization
Novel ?2-Antiplasmin Inactivation for Lysis of Intravascular Thrombi (NAIL-IT) Trial
2023
·
$45.8K
thrombolysis,
antiplasmin,
intravascular,
clinical trial,
lysis
Patterns of Survivors' Recovery Trajectories in the ICECAP trial POST-ICECAP
2023
·
$26K
recovery trajectories,
survivors,
icecap trial,
patterns,
recovery
Surveillance of Acutely Ill Adults with Respiratory Viruses, Including SARS-CoV-2
2022
·
$1.7M
respiratory viruses,
surveillance,
sars-cov-2,
acutely ill adults,
public health
A Multicenter, Adaptive, Randomized, Controlled Trial Platform To Evaluate Safety and Efficacy of Strategies and Treatments for Hospitalized Patients with Respiratory Infections / Appendix E-1: Shio
2022
·
$1.5M
respiratory infections,
hospitalized patients,
treatment strategies,
randomized controlled trial,
efficacy evaluation
A Phase 3, Multicenter, Randomized, Controlled, Open-Label, Assessor-Blinded Study to Evaluate the Efficacy and Safety of Inhaled Isoflurane Delivered via the Sedaconda ACD-S Compared to Intravenous P
2022
·
$866.3K
anesthesia,
drug delivery,
clinical trials,
safety evaluation,
efficacy assessment
ADHS18-181037 - Professional Medical Consultation on Terrorism - Agreement No. CTR058765
2022
·
$450K
medical,
terrorism,
consultation,
professional,
agreement
People
Albert Fiorello
Associate Professor
Anitza Lopez
Clinical Research Coordinator I
Daniel Beskind
Associate Professor
Beth Campbell
Clinical Research Manager I
Christopher Edwards
Associate Clinical Professor
Chad Viscusi
Assistant Professor
Elaine Situ-LaCasse
Associate Professor
Frank Walter
Professor
Hans Bradshaw
Assistant Professor
Isaac Farrell
Assistant Clinical Professor
Nicholas Hurst
Assistant Professor, Emergency Medicine - (Clinical Scholar Track)
Jaiva Larsen
Assistant Clinical Professor, Emergency Medicine - (Clinical Series Track)
John Guisto
Professor
Jarrod Mosier
Professor
John Sakles
Professor
Kurt Denninghoff
Professor
Lawrence Deluca
Associate Professor
Lisa Stoneking
Professor
Matthew Berkman
Clinical Professor
Maggie Drury
Clinical Research Coordinator I
Harvey Meislin
Professor
Milton Lerman
Scientific Analyst I
Robert French
Assistant Professor, Emergency Medicine - (Clinical Scholar Track)
Srikar Adhikari
Professor
Samuel Keim
Department Head
Daniel Spaite
Professor
Anna Waterbrook
Professor
Research expenses history
Funding support
11 funding agencies since 2020
